Functional effects of genetic variants in the 11β-hydroxylase (CYP11B1) gene

被引:15
作者
Barr, Marianne
MacKenzie, Scott M.
Wilkinson, Donna M.
Holloway, Christine D.
Friel, Elaine C.
Miller, Stephen
MacDonald, Tom
Fraser, Robert
Connell, John M. C.
Davies, Eleanor
机构
[1] Univ Glasgow, BHF GCRC, Div Cardiovasc & Med Sci, Blood Pressure Grp, Glasgow G12 8TA, Lanark, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Dundee DD1 9SY, Scotland
基金
英国医学研究理事会;
关键词
ALDOSTERONE SYNTHASE GENE; CONGENITAL ADRENAL-HYPERPLASIA; SINGLE-NUCLEOTIDE POLYMORPHISMS; ESSENTIAL-HYPERTENSION; ANGIOTENSIN-II; BLOOD-PRESSURE; AMINO-ACID; DEFICIENCY; MUTATIONS; PREVALENCE;
D O I
10.1111/j.1365-2265.2006.02673.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective We previously described an association between the -344C/T 5'-untranslated region (UTR) polymorphism in the CYP11B2 (aldosterone synthase) gene and hypertension with a raised aldosterone to renin ratio (ARR); the same genetic variant is also associated with impaired adrenal 11 beta-hydroxylase efficiency. The -344 polymorphism does not seem to be functional, so is likely to be in linkage with variants in CYP11B1 that determine the associated variation in 11 beta-hydroxylase efficiency. We therefore aimed to determine whether there is an association between CYP11B1 variants and hypertension and/or an altered ARR. Design and measurements We screened 160 subjects divided into four groups, normotensive controls, unselected hypertensive subjects, and hypertensive subjects with either a high (>= 750) or low ARR (<= 200), for variants in the coding region of CYP11B1 by single-stranded conformation polymorphism (SSCP) and direct sequencing. The effects of these variants on enzyme function were assessed by conversion of 11-deoxycortisol to cortisol and 11-deoxycorticosterone (DOC) to corticosterone. Results Eight novel missense mutations were identified in the CYP11B1 gene that alter the encoded amino acids: R43Q, L83S, H125R, P135S, F139L, L158P, L186V and T196A. In each case they were heterozygous changes. However, no mutations were identified that could account for hypertension and/or a raised ARR. The variants L158P and L83S severely impaired enzyme function while R43Q, F139L, P135S and T196A enzymes resulted in product levels that were approximately 30-50% that of wild-type levels. The variant enzymes H125R and L186V resulted in substrate-specific alterations in enzyme function. H125R decreased conversion of 11-deoxycortisol to cortisol and L186V increased 11-deoxycortisol conversion. Neither had an effect on the conversion of DOC to corticosterone. Conclusion No variants were identified in the coding region of CYP11B1 that could account for hypertension and/or a raised ARR. However, this in vitro study identifies the importance of these affected residues to enzyme function and will inform subsequent studies of structure-function relationships.
引用
收藏
页码:816 / 825
页数:10
相关论文
共 45 条
  • [1] AMIN HK, 2002, HUM GENET, V210, P294
  • [2] Differential regulation of aldosterone synthase and 11β-hydroxylase transcription by steroidogenic factor-1
    Bassett, MH
    Zhang, Y
    Clyne, C
    White, PC
    Rainey, WE
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 28 (02) : 125 - 135
  • [3] Modelling of three-dimensional structures of cytochromes P45011B1 and 11B2
    Belkina, NV
    Lisurek, M
    Ivanov, AS
    Bernhardt, R
    [J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2001, 87 (04) : 197 - 207
  • [4] Structural analysis and evaluation of the aldosterone synthase gene in hypertension
    Brand, E
    Chatelain, N
    Mulatero, P
    Féry, I
    Curnow, K
    Jeunemaitre, X
    Corvol, P
    Pascoe, L
    Soubrier, F
    [J]. HYPERTENSION, 1998, 32 (02) : 198 - 204
  • [5] Characterization of single-nucleotide polymorphisms in coding regions of human genes
    Cargill, M
    Altshuler, D
    Ireland, J
    Sklar, P
    Ardlie, K
    Patil, N
    Lane, CR
    Lim, EP
    Kalyanaraman, N
    Nemesh, J
    Ziaugra, L
    Friedland, L
    Rolfe, A
    Warrington, J
    Lipshutz, R
    Daley, GQ
    Lander, ES
    [J]. NATURE GENETICS, 1999, 22 (03) : 231 - 238
  • [6] Corticosteroids in essential hypertension: Multiple candidate loci and phenotypic variation
    Connell, JMC
    Kenyon, CJ
    Ingram, M
    Holloway, C
    Jamieson, A
    Panarelli, M
    Inglis, G
    Fraser, R
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (05) : 369 - 374
  • [7] MUTATIONS IN THE CYP11B1 GENE CAUSING CONGENITAL ADRENAL-HYPERPLASIA AND HYPERTENSION CLUSTER IN EXON-6, EXON-7, AND EXON-8
    CURNOW, KM
    SLUTSKER, L
    VITEK, J
    COLE, T
    SPEISER, PW
    NEW, MI
    WHITE, PC
    PASCOE, L
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) : 4552 - 4556
  • [8] An influence of variation in the aldosterone synthase gene (CYP11B2) on corticosteroid responses to ACTH in normal human subjects
    Davies, E
    Holloway, CD
    Ingram, MC
    Friel, EC
    Inglis, GC
    Swan, L
    Hillis, WS
    Fraser, R
    Connell, JMC
    [J]. CLINICAL ENDOCRINOLOGY, 2001, 54 (06) : 813 - 817
  • [9] Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2
    Davies, E
    Holloway, CD
    Ingram, MC
    Inglis, GC
    Friel, EC
    Morrison, C
    Anderson, NH
    Fraser, R
    Connell, JMC
    [J]. HYPERTENSION, 1999, 33 (02) : 703 - 707
  • [10] DESIMONE G, 1985, HYPERTENSION, V7, P613